Evogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Evogliptin. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Evogliptin. |
| Moxifloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Evogliptin can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Evogliptin can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Evogliptin can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Evogliptin can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Methyclothiazide. |
| Chlorthalidone | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Chlorthalidone. |
| Bendroflumethiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Bendroflumethiazide. |
| Metolazone | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Metolazone. |
| Benzthiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Benzthiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Hydroflumethiazide. |
| Indapamide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Indapamide. |
| Chlorothiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Polythiazide. |
| Quinethazone | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Quinethazone. |
| Cyclopenthiazide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Cyclopenthiazide. |
| Epitizide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Epitizide. |
| Amitriptyline | Amitriptyline may decrease the hypoglycemic activities of Evogliptin. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Evogliptin. |
| Imipramine | Imipramine may decrease the hypoglycemic activities of Evogliptin. |
| Nortriptyline | Nortriptyline may decrease the hypoglycemic activities of Evogliptin. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Evogliptin. |
| Trimipramine | Trimipramine may decrease the hypoglycemic activities of Evogliptin. |
| Doxepin | Doxepin may decrease the hypoglycemic activities of Evogliptin. |
| Desipramine | Desipramine may decrease the hypoglycemic activities of Evogliptin. |
| Clomipramine | Clomipramine may decrease the hypoglycemic activities of Evogliptin. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Evogliptin. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Evogliptin. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Evogliptin. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Evogliptin. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Evogliptin. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Evogliptin. |
| Opipramol | Opipramol may decrease the hypoglycemic activities of Evogliptin. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the hypoglycemic activities of Evogliptin. |
| Dibenzepin | Dibenzepin may decrease the hypoglycemic activities of Evogliptin. |
| Quinupramine | Quinupramine may decrease the hypoglycemic activities of Evogliptin. |
| Melitracen | Melitracen may decrease the hypoglycemic activities of Evogliptin. |
| Lofepramine | Lofepramine may decrease the hypoglycemic activities of Evogliptin. |
| Iprindole | Iprindole may decrease the hypoglycemic activities of Evogliptin. |
| Imipramine oxide | Imipramine oxide may decrease the hypoglycemic activities of Evogliptin. |
| Glimepiride | Evogliptin may increase the hypoglycemic activities of Glimepiride. |
| Acetohexamide | Evogliptin may increase the hypoglycemic activities of Acetohexamide. |
| Chlorpropamide | Evogliptin may increase the hypoglycemic activities of Chlorpropamide. |
| Tolazamide | Evogliptin may increase the hypoglycemic activities of Tolazamide. |
| Glyburide | Evogliptin may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Evogliptin may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Evogliptin may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Evogliptin may increase the hypoglycemic activities of Tolbutamide. |
| Gliquidone | Evogliptin may increase the hypoglycemic activities of Gliquidone. |
| Glisoxepide | Evogliptin may increase the hypoglycemic activities of Glisoxepide. |
| Glibornuride | Evogliptin may increase the hypoglycemic activities of Glibornuride. |
| Carbutamide | Evogliptin may increase the hypoglycemic activities of Carbutamide. |
| Metahexamide | Evogliptin may increase the hypoglycemic activities of Metahexamide. |
| Dapagliflozin | Dapagliflozin may increase the hypoglycemic activities of Evogliptin. |
| Canagliflozin | Canagliflozin may increase the hypoglycemic activities of Evogliptin. |
| Leuprolide | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Leuprolide. |
| Goserelin | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Goserelin. |
| Nelfinavir | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Nelfinavir. |
| Indinavir | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Indinavir. |
| Ziprasidone | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Ziprasidone. |
| Etonogestrel | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Etonogestrel. |
| Desogestrel | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Desogestrel. |
| Olanzapine | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Olanzapine. |
| Megestrol acetate | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Megestrol acetate. |
| Clozapine | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Clozapine. |
| Levonorgestrel | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Levonorgestrel. |
| Progesterone | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Progesterone. |
| Chlorpromazine | The therapeutic efficacy of Evogliptin can be decreased when used in combination with Chlorpromazine. |